Carotenoids as modulators of the PI3K/Akt/mTOR pathway: innovative strategies in cancer therapy.

IF 2.8 4区 医学 Q2 ONCOLOGY
Biswajit Kumar Utpal, Zerrouki Dehbia, B M Redwan Matin Zidan, Sherouk Hussein Sweilam, Laliteshwar Pratap Singh, M S Arunkumar, M Sona, Uttam Prasad Panigrahy, R Keerthana, Sandhya Rani Mandadi, Safia Obaidur Rab, Mohammed Ali Alshehri, Doukani Koula, Muath Suliman, Mohamed H Nafady, Talha Bin Emran
{"title":"Carotenoids as modulators of the PI3K/Akt/mTOR pathway: innovative strategies in cancer therapy.","authors":"Biswajit Kumar Utpal, Zerrouki Dehbia, B M Redwan Matin Zidan, Sherouk Hussein Sweilam, Laliteshwar Pratap Singh, M S Arunkumar, M Sona, Uttam Prasad Panigrahy, R Keerthana, Sandhya Rani Mandadi, Safia Obaidur Rab, Mohammed Ali Alshehri, Doukani Koula, Muath Suliman, Mohamed H Nafady, Talha Bin Emran","doi":"10.1007/s12032-024-02551-x","DOIUrl":null,"url":null,"abstract":"<p><p>Cancer progression is primarily driven by the uncontrolled activation of cellular signaling pathways, with the PI3K/Akt/mTOR (PAMT) pathway playing a central role. This pathway significantly contributes to the proliferation and survival of cancer cells, and its hyperactivity is a major challenge in managing several types of malignancies. This article delves into the promising potential of carotenoids, natural pigments found in abundance in fruits and vegetables, as a novel therapeutic strategy for cancer treatment. By specifically targeting and inhibiting the PAMT pathway, carotenoids may effectively disrupt the growth and survival of cancer cells. The article examines the complex mechanisms underlying these interactions and highlights the obstacles faced in cancer treatment. It proposes a compelling approach to developing therapies that leverage natural products to target this critical pathway, offering a fresh perspective on cancer treatment. Further research is essential to enhance the therapeutic efficacy of these compounds.</p>","PeriodicalId":18433,"journal":{"name":"Medical Oncology","volume":"42 1","pages":"4"},"PeriodicalIF":2.8000,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12032-024-02551-x","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Cancer progression is primarily driven by the uncontrolled activation of cellular signaling pathways, with the PI3K/Akt/mTOR (PAMT) pathway playing a central role. This pathway significantly contributes to the proliferation and survival of cancer cells, and its hyperactivity is a major challenge in managing several types of malignancies. This article delves into the promising potential of carotenoids, natural pigments found in abundance in fruits and vegetables, as a novel therapeutic strategy for cancer treatment. By specifically targeting and inhibiting the PAMT pathway, carotenoids may effectively disrupt the growth and survival of cancer cells. The article examines the complex mechanisms underlying these interactions and highlights the obstacles faced in cancer treatment. It proposes a compelling approach to developing therapies that leverage natural products to target this critical pathway, offering a fresh perspective on cancer treatment. Further research is essential to enhance the therapeutic efficacy of these compounds.

类胡萝卜素作为 PI3K/Akt/mTOR 通路的调节剂:癌症治疗的创新策略。
癌症进展的主要驱动因素是细胞信号通路的失控激活,其中 PI3K/Akt/mTOR (PAMT) 通路起着核心作用。该通路对癌细胞的增殖和存活起着重要作用,其过度活跃是治疗多种恶性肿瘤的一大挑战。类胡萝卜素是大量存在于水果和蔬菜中的天然色素,本文深入探讨了类胡萝卜素作为一种新型癌症治疗策略的巨大潜力。类胡萝卜素通过特异性靶向和抑制 PAMT 通路,可以有效地破坏癌细胞的生长和存活。文章探讨了这些相互作用的复杂机制,并强调了癌症治疗所面临的障碍。文章提出了一种令人信服的方法,利用天然产品开发针对这一关键途径的疗法,为癌症治疗提供了一个全新的视角。进一步的研究对于提高这些化合物的疗效至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medical Oncology
Medical Oncology 医学-肿瘤学
CiteScore
4.20
自引率
2.90%
发文量
259
审稿时长
1.4 months
期刊介绍: Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly experimental therapeutics within the fields of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信